Admission hyperglycemia and length of hospital stay in patients with diabetes and heart failure: A prospective cohort study

Congestive Heart Failure

Volumn 14, Issue 3, 2008, Pages 117-120

  Gebreegziabher, Yohannes ^a   McCullough, Peter A ^b   Bubb, Chard ^a   Loney Hutchinson, Lesel ^a   Makaryus, John N ^c   Anand, Naveen ^a   Divakaran, Vijay ^a   Akhrass, Philippe ^a   Alam, Anis ^a   Gizycki, Hans von ^d   McFarlane, Samy I ^a  

^a Downstate Health Sciences University   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART STROKE VOLUME; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; LENGTH OF STAY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TIME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES COMPLICATIONS; FEMALE; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT ADMISSION; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS;

EID: 53049103045     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2008.07569.x     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Trends in Hospitalizations for Heart Failure by Age Group, 1979-2004, United States. Heart Failure Fact Sheet. Atlanta, GA: Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention; 2006.
2. Nichols GA, Gullion CM, Koro CE, et al. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004;27:1879-1884.
3. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
4. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A-13A.
5. Bhatia V, Wilding GE, Dhindsa G, et al. Association of poor glycemic control with prolonged hospital stay in patients with diabetes admitted with exacerbation of congestive heart failure. Endocr Pract. 2004;10(6):467-471.
6. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med. 2004;21(4):305-310.
7. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109(12):1497-1502.
8. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
9. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-412.
10. Iribarren C, Karter AJ, Go AS, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103(22):2668-2673.
11. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982.
12. Whitcomb BW, Pradhan EK, Pittas AG, et al. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med. 2005;33(12):2772-2777.
13. Stettler C, Allemann S, Juni P, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J. 2006;152(1):27-38.
14. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998;97(17):1695-1701.
15. Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24(1):5-10.
16. Schmidt AM, Hori O, Brett J, et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb. 1994;4(10):1521-1528.
17. Johansen JS, Harris AK, Rychly DJ, et al. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005;4(1):5.
18. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63(4):582-592.
19. Twigg SM, Chen MM, Joly AH, et al. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus.Endocrinology. 2001;142(5):1760-1769.
20. Ido Y, Kilo C, Williamson JR. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction. Nephrol Dial Transplant. 1996;11(suppl 5):72-75.
21. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia. 1993;36:1119-1125.
22. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Circulation. 2002;106:2067-2072.
23. Shizukuda Y, Reyland ME, Buttrick PM. Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol Heart Circ Physiol. 2002;282:H1625-H1634.
24. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
25. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem. 1998;180:53-57.
26. Garvey WT, Hardin D, Juhaszova M, et al. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol. 1993;264:H837-H844.
27. Takeda N, Nakamura I, Hatanaka T, et al. Myocardial mechanical and myosin isoenzyme alterations in streptozotocin-diabetic rats. Jpn Heart J. 1988;29:455-463.
28. Abe T, Ohga Y, Tabayashi N, et al. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol. 2002;282:H138-H148.
29. Dhalla NS, Liu X, Panagia V, et al. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res. 1998;40:239-247.
30. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982.